HCRT and depressive disorder: These behavioral results from pharmacological and molecular manipulations collectively suggest that blockage of endogenous orexinergic inputs in VP results in depressive-like behaviors, and OX1R and OX2R may have the homogeneous contribution to the protective effect of orexin on depression.